MVision megavoltage cone-beam imaging package has received FDA clearance. MVision is a unique volumetric inline target imaging solution and the natural next step in Image Guided Radiation Therapy (IGRT). Designed to work with Siemens’ linear accelerators, the system is the first commercial implementation of cone-beam technology utilizing a standard radiotherapy treatment beam. MVision makes it possible for the megavoltage (MV) source used for treatment to also create a 3-D image of the patient, enabling clinicians to “see inside” the patient at the most appropriate moment.


Additional Content

News | Radiation Therapy

Oct. 1, 2026 — At ASTRO 2026 Elekta highlighted new data showing unprecedented long-term survival outcomes for patients ...

Time October 05, 2026
arrow
News | Radiology Imaging

Sept. 22, 2026 — Clinicians’ hands can receive up to 1,000 times more radiation than other parts of the body during ...

Time September 22, 2026
arrow
News | Interventional Radiology

June 29, 2026 – GE HealthCare has introduced Allia platform upgrade pathways designed to help customers modernize select ...

Time July 01, 2026
arrow
News | Interventional Radiology

Feb.12, 2026 — The University of South Florida’s Center for Advanced Medical Learning and Simulation (CAMLS), part of ...

Time February 23, 2026
arrow
News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
Subscribe Now